Heart device maker Thoratec Corp. said Wednesday that its third-quarter profit almost doubled on strong growth in its cardiovascular division. The company also raised the low end of its full-year revenue forecast, and its shares rose more than 10 percent. The…

Email this Article
Add to del.icio.us
Add to digg
Add to Facebook




Corporation – Health – Conditions and Diseases – Cardiovascular Disorders – Heart Disease

Credit:
Thoratec 3Q profit surges on heart pump success